Calpol infant suspension

Calpol is one of the most recognized pharmaceutical brands in the world, specifically known for its liquid paracetamol formulations for infants and children. It was originally developed in the United Kingdom and has become a household staple for managing pain and fever in pediatric care.

Historically, the brand was established by the British company Calmic Ltd. Over the decades, it has undergone several ownership changes through various mergers and acquisitions within the pharmaceutical industry. For many years, it was part of the GlaxoSmithKline (GSK) portfolio until a significant restructuring of their consumer healthcare divisions.

Today, Calpol is owned by Kenvue, which was effectively spun off from the consumer health division of Johnson & Johnson in 2023. While manufacturing occurs in multiple locations globally to meet local demand, the brand remains a flagship product in the United Kingdom and various European markets. Kenvue continues to manage the brand's expansive line of children's health products, including sugar-free and color-free variations.